SEARCH RESULT

Total Matching Records found : 63

Drug makers may dodge price control-Sushmi Dey

-The Business Standard The proposed pharma pricing policy may give room to drug makers to escape price control. While the policy is primarily aimed at making essential medicines affordable, many feel the spirit is missing in the recommendations put forward by a group of ministers a few days ago. For instance, the ministerial panel has proposed to regulate prices of only 348 essential medicines and keep combination products out of control —...

More »

Red flag in front of FDI in pharma too-Pranab Dhal Samanta

-The Indian Express At a time when the government is struggling to get past objections from its coalition partners to attract investment in certain sectors such as retail, aviation and pensions fund management, a grim internecine ministerial battle has applied the brakes on foreign direct investment flow into one of the more attractive and lucrative sectors — pharmaceuticals. Clearances for over Rs 1,000 crore FDI in this sector, the second largest in...

More »

Hard at work, the very special correspondent by Aman Sethi

One man's quest to make the right to information the right to action Subhash Chandra Agrawal doesn't drink tea, eat onions, watch movies, listen to music, or want to raise children in this corrupt and polluted world. A cloth merchant from Chandni Chowk, Mr. Agrawal (62) follows the news and files Right to Information (RTI) requests: on the selection criteria for national awards, the assets of judges, the prevalence of bigamy among...

More »

Ranbaxy's finest hour

India joins global drug discovery league The launch by Ranbaxy last week of Synriam, a new drug to treat malaria, is an important milestone. Having made its name by manufacturing generic (off patent) drugs cheaply, India’s pharmaceutical industry has struggled to achieve original drug discovery since the Uruguay Round of trade negotiations signalled the onset of product patents in India. It began to be realised, in time, that there was...

More »

Malaria drug, made in India

-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close